Latest Articles

  • Prevention of venous thromboembolism in the hospitalized medical patient
    Amir K. Jaffer, MD, Alpesh N. Amin, MD, MBA, Daniel J. Brotman, MD, Steven B. Deitelzweig, MD, Sylvia C. McKean, MD and Alex C. Spyropoulos, MD
    Cleveland Clinic Journal of Medicine April 2008, 75 (4 suppl 3) S7-S16;
  • Prevention of venous thromboembolism in the orthopedic surgery patient
    Amir K. Jaffer, MD, Steven B. Deitelzweig, MD, Sylvia C. McKean, MD, Alpesh N. Amin, MD, MBA, Daniel J. Brotman, MD and Alex C. Spyropoulos, MD
    Cleveland Clinic Journal of Medicine April 2008, 75 (4 suppl 3) S27-S36;

    This supplement is based on the proceedings of a roundtable convened in Miami, FL, on December 1, 2007, by the Cleveland Clinic Center for Continuing Education and the Cleveland Clinic Journal of Medicine.

  • Prevention of venous thromboembolism in the cancer surgery patient
    Amir K. Jaffer, MD, Alex C. Spyropoulos, MD, Daniel J. Brotman, MD, Alpesh N. Amin, MD, MBA, Steven B. Deitelzweig, MD and Sylvia C. McKean, MD
    Cleveland Clinic Journal of Medicine April 2008, 75 (4 suppl 3) S17-S26;
  • Accuracy of the physical examination in evaluating pleural effusion
    Accuracy of the physical examination in evaluating pleural effusion
    Enrique Diaz-Guzman, MD and Marie M. Budev, DO, MPH
    Cleveland Clinic Journal of Medicine April 2008, 75 (4) 297-303;

    A careful physical examination is a valuable and noninvasive means of assessing pleural effusions and should be routinely performed in every patient in whom this condition is suspected.

  • A new series, an old concept, continued value
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2008, 75 (4) 257;

    This month we introduce a new series, The Physical Examination, kicked off by a paper on evaluating pleural effusions. We encourage you to submit your suggestions for topics.

  • Interpreting the Charisma Study
    Mihir R. Bakhru, MD and Deepak L. Bhatt, MD
    Cleveland Clinic Journal of Medicine April 2008, 75 (4) 289-295;

    In patients at risk of myocardial infarction or stroke, two antiplatelet drugs are not always better than one.

  • Diffuse alveolar hemorrhage: Diagnosing it and finding the cause
    Octavian C. Ioachimescu, MD and James K. Stoller, MD
    Cleveland Clinic Journal of Medicine April 2008, 75 (4) 258-280;

    Diffuse alveolar hemorrhage can complicate a large number of clinical conditions. It may present in different ways and may be life-threatening, and it poses an important challenge for the clinician.

  • A review of spinal arachnoid cysts
    Gwyneth Hughes, MD, Kene Ugokwe, MD and Edward C. Benzel, MD
    Cleveland Clinic Journal of Medicine April 2008, 75 (4) 311-315;

    The symptoms of spinal arachnoid cysts are variable and nonspecific, so these cysts are commonly misdiagnosed as herniated disks. Many are discovered incidentally.

  • What role will ‘gliptins’ play in glycemic control?
    Zachary Bloomgarden, MD and Andrew Drexler, MD
    Cleveland Clinic Journal of Medicine April 2008, 75 (4) 305-310;

    Sitagliptin (Januvia) is now available, vildagliptin (Galvus) is awaiting approval, and other “gliptins” are under development. Their greatest appeal appears to be their ability to stimulate insulin production with little risk of hypoglyecmia.

  • Overview of breast cancer staging and surgical treatment options
    Risal Djohan, MD, James E. Zins, MD, David K. Rolston, MD, Robert Hermann, MD, Clarisa Hammer, DO, Alicia Fanning, MD and Joseph Crowe, MD
    Cleveland Clinic Journal of Medicine March 2008, 75 (3 suppl 1) S10-S16;

Pages